Positive or close margins in breast conserving surgery: Is re-excision always necessary?

European Journal of Surgical Oncology

Volumn 38, Issue 5, 2012, Pages 399-406

  Gurdal, S O ^a   Karanlik, H ^a   Cabioglu, N ^b   Ozcinar, B ^a   Yavuz, E ^c   Tuzlali, S ^c   Ozmen, V ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Breast conserving surgery; Margin; Re excision

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER SURGERY; GENE OVEREXPRESSION; HER2 ENRICHED BREAST CANCER; HISTOPATHOLOGY; HUMAN; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CANCER; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REOPERATION; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM, RESIDUAL; ODDS RATIO; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REOPERATION; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84859435541     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.02.182     Document Type: Article

References (39)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41. (Pubitemid 35176242)
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32. (Pubitemid 35176241)
3. Schwartz GF, Veronesi U, Clough KB, et al. Consensus conference committee. consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Breast J 2006;12:398-407.
4. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383-93. (Pubitemid 35335942)
5. Cellini C, Hollenbeck ST, Christos P, et al. Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol 2004;11:915-20. (Pubitemid 40486677)
6. Swanson GP, Rynearson K, Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 2002;25:438-41. (Pubitemid 35154944)
7. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 1999;45:885-91. (Pubitemid 29525451)
8. Landheer ML, Klinkenbijl JH, Pasker-de Jong PC, Wobbes T. Residual disease after excision of non-palpable breast tumours: analysis of tumour characteristics. Eur J Surg Oncol 2004;30:824-8. (Pubitemid 39186067)
9. Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 2003;57:979-85. (Pubitemid 37324115)
10. DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998;82:2212-20. (Pubitemid 28240828)
11. Luu HH, Otis CN, Reed Jr WP, Garb JL, Frank JL. The unsatisfactory margin in breast cancer surgery. Am J Surg 1999;178:362-6. (Pubitemid 30001513)
12. ZavagnoG,Goldin E,Mencarelli R, et al. Role of resection margins in patients treatedwith breast conservation surgery. Cancer 2008;112:1923-31. (Pubitemid 351574067)
13. O'Brien KM, Cole SR, Tse CK, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010 Dec 15;16(24):6100-10.
14. Genestie C, Zafrani B, Asselain B, et al. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res 1998;18:571-6. (Pubitemid 28174874)
15. Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993;218:22-8. (Pubitemid 23215189)
16. Boughey JC, Peintinger F, Meric-Bernstam F, et al. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg 2006;244:464-70.
17. Cabioglu N, Hunt KK, Sahin AA, et al. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 2007;14:1458-71. (Pubitemid 46536814)
18. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668-75. (Pubitemid 30220545)
19. Holland R, Veling SH, Mravunac M. Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;56:979-90.
20. Chism DB, Freedman GM, Li T, Anderson PR. Re-excision of margins before breast radiation-diagnostic or therapeutic? Int J Radiat Oncol Biol Phys 2006;65:1416-21. (Pubitemid 44425200)
21. Dillon MF, Hill AD, Quinn CM, McDermott EW, O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006;13:333-9. (Pubitemid 43255916)
22. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 2002;94:1917-24.
23. Scopa CD, Aroukatos P, Tsamandas AC, Aletra C. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma. Breast J 2006;12:150-3.
24. Graham RA, Homer MJ, Katz J, Rothschild J, Safaii H, Supran S. The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg 2002;184:89-93. (Pubitemid 34880211)
25. Dooley WC, Parker J. Understanding the mechanisms creating false positive lumpectomy margins. Am J Surg 2005;190:606-8. (Pubitemid 41306087)
26. Héquet D, Bricou A, Delpech Y, Barranger E. Surgical management modifications following systemic additional shaving of cavity margins in breast-conservation treatment. Ann Surg Oncol 2011;18(1). [online].
27. Bani MR, Lux MP, Heusinger K, et al. Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol 2009;35:32-7.
28. Kurniawan ED, Wong MH, Windle I, et al. Predictors of surgical margin status in breast-conserving surgery within a breast Screening program. Ann Surg Oncol 2008;15(9):2542-9.
29. Sabel MS, Rogers K, Griffith K, et al. Residual disease after reexcision lumpectomy for close margins. Surg Oncol 2009;99:99-103.
30. Vicini FA, Eberlein TJ, Connolly JL, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991;214:200-5.
31. Schnitt SJ, Connolly JL. Processing and evaluation of breast excision specimens. A clinically oriented approach. Am J Clin Pathol 1992;98:125-37.
32. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986;57:1717-24.
33. Nixon A, Neuberg D, Hayes D, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-94. (Pubitemid 24145313)
34. Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 2001;29:3885-91.
35. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010;28:1684-91.
36. Fisher B, Dignam J, Bryant J, Wolmark N. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl. Cancer Inst 2001;93:684-90. (Pubitemid 32492809)
37. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with inavsive breast cancers of one centimeter or less. J Clin Oncol 2002;20:4141-9. (Pubitemid 35191016)
38. Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy. A 27-year single-institution experience. Cancer 2005;104:20-9.
39. Cheang Cheang MCU, Chia SK, Voduc D, Gao D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009;101:736-50.